Budget Implementation Act, 2019, No. 1, S.C. 2019, c. 29

Section 181

Studies — positron-emitting radiopharmaceuticals

Cite as Budget Implementation Act, 2019, No. 1, S.C. 2019, c. 29, s. 181 · current to March 31, 2026 · Act last amended March 26, 2026

Statute Watch

Get an alert when a bill in Parliament would change this section, and every time it moves.

The text

A person that, immediately before the coming into force of section 166, is authorized under Division 3 of Part C of the Food and Drug Regulations to sell or import a positron-emitting radiopharmaceutical for the purposes of a study is deemed to be the holder, in respect of that positron-emitting radiopharmaceutical, of an authorization referred to in section 3.1 of the Food and Drugs Act, as enacted by that section 166.
Read the Budget Implementation Act, 2019, No. 1 on the Justice Laws Website ↗

Bills in Parliament that would change this section 0

No bill we hold would amend or repeal this section.